Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Resolvyx Pharmaceuticals (developing therapies for inflammatory diseases and related complications) raised $25mm through its Series B financing round led by first-time backer QVT, which contributes a member to the company's board. Other new investors Radius Ventures and Biogen Idec New Ventures were joined by returning shareholders Atlas Venture, CHL Medical Partners, and Flagship Ventures.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?